Macular Degeneration
Showing NaN - NaN of 26
Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)
Recruiting
- Macular Degeneration
- Geographic Atrophy
- IONIS-FB-LRx
- Placebo
-
Phoenix, Arizona
- +83 more
Aug 19, 2022
Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)
Completed
- Age-Related Maculopathy
- +4 more
- RN6G
- Placebo
-
Campbell, California
- +23 more
May 10, 2022
Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)
Completed
- Geographic Atrophy
- Macular Degeneration
- Zimura
- Sham
-
Phoenix, Arizona
- +77 more
Mar 17, 2022
Macular Degeneration Trial in Worldwide (Ranibizumab)
Completed
- Macular Degeneration
- Ranibizumab
-
Gilbert, Arizona
- +101 more
Mar 11, 2022
Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)
Completed
- Macular Degeneration
- Abicipar Pegol
- +2 more
-
Birmingham, Alabama
- +186 more
Jul 17, 2020
Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)
Completed
- Macular Degeneration
- Abicipar Pegol
- +2 more
-
Phoenix, Arizona
- +150 more
Jul 16, 2020
Retinal Drusen, Age-related Macular Degeneration, Macular Degeneration Trial in Austin (Lumega-Z, AREDS2)
Completed
- Retinal Drusen
- +2 more
- Lumega-Z
- AREDS2
-
Austin, TexasEye Clinic of Austin
May 9, 2019
Geographic Atrophy, Macular Degeneration Trial in Worldwide (400 µg Brimonidine Implant, Sham)
Terminated
- Geographic Atrophy
- Macular Degeneration
- 400 µg Brimonidine Implant
- Sham
-
Phoenix, Arizona
- +40 more
Mar 29, 2019
Macular Degeneration Trial in Worldwide (pazopanib eye drops, , ranibizumab intravitreal injection)
Completed
- Macular Degeneration
- pazopanib eye drops
- +2 more
-
Peoria, Arizona
- +76 more
Dec 7, 2017
Macular Degeneration Trial in France, Germany, United States (pazopanib eye drops)
Terminated
- Macular Degeneration
- pazopanib eye drops
-
Phoenix, Arizona
- +14 more
Aug 23, 2017
Macular Degeneration Trial in Worldwide (Regorafenib, ophthalmic oily suspension (BAY73-4506), Sham IVT, Ranibizumab)
Terminated
- Macular Degeneration
- Regorafenib, ophthalmic oily suspension (BAY73-4506)
- +3 more
-
Tucson, Arizona
- +148 more
Jul 25, 2016
Macular Degeneration, Choroidal Neovascularization Trial in Austin (Verteporfin photodynamic therapy, Pegaptanib, Triamcinolone
Completed
- Macular Degeneration
- Choroidal Neovascularization
- Verteporfin photodynamic therapy
- +2 more
-
Austin, TexasNovartis Investigational Site
Mar 3, 2016
Macular Degeneration Trial in Canada, United States (bevasiranib, ranibizumab)
Terminated
- Macular Degeneration
-
Phoenix, Arizona
- +59 more
Sep 29, 2014
Macular Degeneration Trial in Worldwide (rhuFab V2 (ranibizumab))
Completed
- Macular Degeneration
- rhuFab V2 (ranibizumab)
-
Tucson, Arizona
- +81 more
Mar 18, 2014
Macular Degeneration Trial in Canada, United States (ranibizumab, aflibercept injection (VEGF Trap-Eye, BAY86-5321))
Completed
- Macular Degeneration
- ranibizumab
- aflibercept injection (VEGF Trap-Eye, BAY86-5321)
-
Birmingham, Alabama
- +187 more
Dec 20, 2012
Macular Degeneration, Age-related Macular Degeneration Trial in Fargo, Austin (Pazopanib eye drops and Allergen Refresh Plus eye
Completed
- Macular Degeneration
- Age-related Macular Degeneration
- Pazopanib eye drops and Allergen Refresh Plus eye drops
-
Fargo, North Dakota
- +1 more
Mar 15, 2012
Macular Degeneration Trial in Worldwide (Epi-Rad90™ Ophthalmic System, ranibizumab)
Unknown status
- Macular Degeneration
- Epi-Rad90™ Ophthalmic System
- ranibizumab
-
Phoenix, Arizona
- +31 more
Jul 26, 2011
Macular Degeneration, Choroidal Neovascularization Trial in Canada, United States (Verteporfin Photodynamic Therapy,
Completed
- Macular Degeneration
- Choroidal Neovascularization
- Verteporfin Photodynamic Therapy
- +3 more
-
Tucson, Arizona
- +42 more
Mar 23, 2011